Učitavanje...

Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009

BACKGROUND: The influenza A/H1N1 pandemic in 2009 created an urgent need to develop vaccines for mass immunization. To guide decisions regarding the optimal immunization dosage and schedule for adults, we evaluated two monovalent, inactivated, unadjuvanted H1N1 influenza vaccines in independent, but...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chen, Wilbur H., Winokur, Patricia L., Edwards, Kathryn M., Jackson, Lisa A., Wald, Anna, Walter, Emmanuel B., Noah, Diana L., Wolff, Mark, Kotloff, Karen L.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490194/
https://ncbi.nlm.nih.gov/pubmed/22537984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.04.044
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!